A once-weekly dual GIP + GLP-1 agonist (tirzepatide) prepared in a U.S.-licensed 503A pharmacy.
You inject from a vial with a small syringe instead of a pre-filled pen — lower price, no paperwork.
Active: tirzepatide, titrated from a 2.5 mg starting dose to a clinically appropriate maintenance dose.
Excipients: sodium chloride, water for injection, and a sterile buffer system standard to injectable preparations.
Pharmacy: a U.S.-licensed 503A compounding pharmacy operating in an FDA-registered facility. Compounded preparations are not FDA-approved as finished products.
Draw your dose and inject once weekly on the same day each week, subcutaneously into the stomach, thigh, or upper arm.
Your provider increases the dose every 4 weeks based on tolerance and progress.
Tirzepatide is a Y-shaped molecule that docks into the GIP and GLP-1 receptors at the same time — a broader fullness signal than GLP-1 alone, which is why average results in trials run higher.
Billed every 4 weeks. You start on the lowest dose at $249/mo; if your provider steps you up, that dose band’s price applies from then on — up to $349/mo. No membership fee. Cancel anytime.
Create your account and tell us about your health and goals — about 3 minutes. Cash pay, no membership fee; you pay only for your medication.
A licensed U.S. provider reviews your intake and decides whether tirzepatide is the right call for you. Most days, under 24 hours.
If prescribed, you get a tailored titration schedule — starting dose, step-up cadence, and side-effect support. Cash pay, no paperwork.
From prescription to your door in days, refrigerated. Cold-chain overnight where available. Refills auto-renew.
What you get with Teledris:
Compounded · 503A
Tirzepatide engages two appetite receptors — a broader fullness signal than GLP-1 alone. Compounded in the U.S. at a fraction of branded retail. Cash pay, from $249/mo.
Pricing
Cash pay, billed every 4 weeks — cancel anytime. This is the starting-dose price. If your provider titrates you to a higher dose, that dose’s price applies from then on. No membership fee.
Both are once-weekly injections. Tirzepatide hits two appetite receptors instead of one, and trial averages run higher. Semaglutide has the longer weight-management track record.
Find my fit*Cash pay, billed every 4 weeks — cancel anytime. The price shown is the starting dose; higher dose bands cost more, up to $349/mo. No membership fee. A prescription is not guaranteed and is issued only after provider review.
1 SURMOUNT-OSA trial showed reduced obstructive sleep apnea events with tirzepatide at 52 weeks vs placebo. Compounded preparations are not separately trialed; talk to your provider.
FAQ
It is prepared in a U.S.-licensed 503A compounding pharmacy operating in an FDA-registered, state-licensed facility. A licensed provider reviews your intake first and only prescribes if tirzepatide is the right call for you. Compounded preparations are not FDA-approved as finished products.
